Evidence map›Paper›PMID 33203363›Full record

ArticleBMC microbiology2020

Utilization of different MurNAc sources by the oral pathogen Tannerella forsythia and role of the inner membrane transporter AmpG.

Valentina M T Mayer, Markus B Tomek, Rudolf Figl, Marina Borisova, Isabel Hottmann, Markus Blaukopf, Friedrich Altmann, Christoph Mayer, Christina Schäffer

Open access · goldAbstract read
In one paragraph

Article in BMC microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Obtaining Muramic Acid fromLife (Basel, Switzerland) · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Valentina M T MayerDepartment of NanoBiotechnology, NanoGlycobiology unit, Universität für Bodenkultur Wien, Vienna, Austria.
Markus B TomekDepartment of NanoBiotechnology, NanoGlycobiology unit, Universität für Bodenkultur Wien, Vienna, Austria.
Rudolf FiglDepartment of Chemistry, Institute of Biochemistry, Universität für Bodenkultur Wien, Vienna, Austria.
Marina BorisovaDepartment of Biology, Eberhard Karls Universität Tübingen, Microbiology/Glycobiology, Interfaculty Institute of Microbiology and Infection Medicine Tübingen, Tübingen, Germany.
Isabel HottmannDepartment of Biology, Eberhard Karls Universität Tübingen, Microbiology/Glycobiology, Interfaculty Institute of Microbiology and Infection Medicine Tübingen, Tübingen, Germany.
Markus BlaukopfDepartment of Chemistry, Institute of Organic Chemistry, Universität für Bodenkultur Wien, Vienna, Austria.
Friedrich AltmannDepartment of Chemistry, Institute of Biochemistry, Universität für Bodenkultur Wien, Vienna, Austria.
Christoph MayerDepartment of Biology, Eberhard Karls Universität Tübingen, Microbiology/Glycobiology, Interfaculty Institute of Microbiology and Infection Medicine Tübingen, Tübingen, Germany. christoph.mayer@uni-tuebingen.de.
Christina SchäfferDepartment of NanoBiotechnology, NanoGlycobiology unit, Universität für Bodenkultur Wien, Vienna, Austria. christina.schaeffer@boku.ac.at.ORCID 0000-0003-1613-7258
BOKU University · ATUniversity of Tübingen · DEUniversity of Vienna · AT

Funding

Austrian Science Fund FWF I 2875Austrian Science Fund FWF P 26836Austrian Science Fund FWF P 27374Austrian Science Fund FWF W 1224
6 · The paper itself

Abstract

backgroundThe Gram-negative oral pathogen Tannerella forsythia strictly depends on the external supply of the essential bacterial cell wall sugar N-acetylmuramic acid (MurNAc) for survival because of the lack of the common MurNAc biosynthesis enzymes MurA/MurB. The bacterium thrives in a polymicrobial biofilm consortium and, thus, it is plausible that it procures MurNAc from MurNAc-containing peptidoglycan (PGN) fragments (muropeptides) released from cohabiting bacteria during natural PGN turnover or cell death. There is indirect evidence that in T. forsythia, an AmpG-like permease (Tanf_08365) is involved in cytoplasmic muropeptide uptake. In E. coli, AmpG is specific for the import of N-acetylglucosamine (GlcNAc)-anhydroMurNAc(-peptides) which are common PGN turnover products, with the disaccharide portion as a minimal requirement. Currently, it is unclear which natural, complex MurNAc sources T. forsythia can utilize and which role AmpG plays therein.

resultsWe performed a screen of various putative MurNAc sources for T. forsythia mimicking the situation in the natural habitat and compared bacterial growth and cell morphology of the wild-type and a mutant lacking AmpG (T. forsythia ΔampG). We showed that supernatants of the oral biofilm bacteria Porphyromonas gingivalis and Fusobacterium nucleatum, and of E. coli ΔampG, as well as isolated PGN and defined PGN fragments obtained after enzymatic digestion, namely GlcNAc-anhydroMurNAc(-peptides) and GlcNAc-MurNAc(-peptides), could sustain growth of T. forsythia wild-type, while T. forsythia ΔampG suffered from growth inhibition. In supernatants of T. forsythia ΔampG, the presence of GlcNAc-anhMurNAc and, unexpectedly, also GlcNAc-MurNAc was revealed by tandem mass spectrometry analysis, indicating that both disaccharides are substrates of AmpG. The importance of AmpG in the utilization of PGN fragments as MurNAc source was substantiated by a significant ampG upregulation in T. forsythia cells cultivated with PGN, as determined by quantitative real-time PCR. Further, our results indicate that PGN-degrading amidase, lytic transglycosylase and muramidase activities in a T. forsythia cell extract are involved in PGN scavenging.

conclusionT. forsythia metabolizes intact PGN as well as muropeptides released from various bacteria and the bacterium's inner membrane transporter AmpG is essential for growth on these MurNAc sources, and, contrary to the situation in E. coli, imports both, GlcNAc-anhMurNAc and GlcNAc-MurNAc fragments.

Indexed as

Bacterial ProteinsBiofilmsCell WallGene ExpressionMembrane Transport ProteinsMouthMuramic AcidsPeptidoglycanSubstrate SpecificityTannerella forsythiaAmpG protein, Bacteriaanhydro-N-acetylmuramic acidBacterial ProteinsMembrane Transport ProteinsMuramic AcidsN-acetylmuramic acidPeptidoglycanAmpG permeaseAnhydro-N-acetylmuramic acidMuropeptidesN-acetylmuramic acid sourcesOral biofilmPeptidoglycanTannerella forsythia

Identifiers

PMID33203363
PMCPMC7670621
OpenAlexW3106303011

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.